RECRUITING: Rett REVOLUTION vorinostat trial – Colombia

[admin]

Status: RecruitingStudy: Rett REVOLUTION exploratory vorinostat study
Registry number: NCT07150013
Location: Medellín, Colombia
Participants: Females aged 6–21 years

What is being studied?
This small exploratory study is evaluating the safety and possible effects of oral vorinostat in typical Rett syndrome. It uses a placebo baseline followed by increasing dose levels. Participants must have a documented disease-causing MECP2 variant and be in the post-regression phase.

Contact: Dr Neal I. Muni — +1 857 404 8252 — neal.muni@unravel.bio
Official study record: https://clinicaltrials.gov/study/NCT07150013

Information checked 3 September 2026. This is early-stage research and benefit is not established. Confirm current eligibility directly with the investigators and discuss it with the person’s Rett specialist.